Your browser doesn't support javascript.
loading
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study.
Capdevila, Jaume; Krajewska, Jolanta; Hernando, Jorge; Robinson, Bruce; Sherman, Steven I; Jarzab, Barbara; Lin, Chia-Chi; Vaisman, Fernanda; Hoff, Ana O; Hitre, Erika; Bowles, Daniel W; Williamson, Denise; Levytskyy, Roman; Oliver, Jennifer; Keam, Bhumsuk; Brose, Marcia S.
Afiliação
  • Capdevila J; Gastrointestinal and Endocrine Tumor Unit, Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), IOB Quiron-Teknon, Barcelona, Spain.
  • Krajewska J; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
  • Hernando J; Vall d'Hebron University Hospital, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Robinson B; Department of Medicine, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.
  • Sherman SI; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jarzab B; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
  • Lin CC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Vaisman F; Department of Endocrinology, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
  • Hoff AO; Department of Endocrinology, Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil.
  • Hitre E; Department of Medical Oncology, The Multidisciplinary Head and Neck Cancer Center, Országos Onkológiai Intézet, Budapest, Hungary.
  • Bowles DW; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Williamson D; Department of Biostatistics, Exelixis, Inc., Alameda, California, USA.
  • Levytskyy R; Department of Medical Affairs, Exelixis, Inc., Alameda, California, USA.
  • Oliver J; Department of Clinical Development, Exelixis, Inc., Alameda, California, USA.
  • Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Brose MS; Department of Medical Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Thyroid ; 34(3): 347-359, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38062732
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Quinolinas / Neoplasias da Glândula Tireoide / Adenocarcinoma / Anilidas / Antineoplásicos Limite: Aged / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Quinolinas / Neoplasias da Glândula Tireoide / Adenocarcinoma / Anilidas / Antineoplásicos Limite: Aged / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article